Lipid Management: The Ins and Outs of Inclisiran Lipid Management: The Ins and Outs of Inclisiran

Christopher V. DeSimone, MD, PhD, and Stephen L. Kopecky, MD, discuss lipid management and the use of inclisiran, an siRNA drug that inhibits the RNA from making PCSK9.Mayo Clinic

Source: Medscape ObGyn and Womens Health Headlines - December 5, 2022 Category: OBGYN Tags: Cardiology Commentary Source Type: news